Funding Priority

Focus on Faculty:
Investing in the Best

We are revolutionizing the possibilities for healthcare in our research labs every day. From treatments for diseases to discoveries that spark new companies, our school is setting the example for game-changing impact. The research taking place is groundbreaking and highly collaborative.

UNC Eshelman School of Pharmacy

    Investing in the Best and Brightest

    The competition for exceptional faculty is fierce. Support for endowed professorships helps us recruit and retain world-renowned leaders who are shaping the next generation of pharmacists and contributing to humanity’s understanding of disease treatment. Angela Kashuba, Pharm.D., our John A. and Deborah S. McNeill Jr., Distinguished Professor of Pharmacy, is a perfect example of the critical role our school plays in advancing disease treatment. She chairs our Division of Pharmacotherapy and Experimental Therapeutics and directs the UNC Center for AIDS Research Clinical Pharmacology and Analytical Chemistry Core.

    Her work with this group has discovered gender differences in drug effectiveness that are game changing in optimizing antiretroviral pharmacology for the treatment, prevention and eradication of HIV. Preeminent faculty like Dr. Kashuba are translating discoveries into better education for our students, economic benefits for North Carolina and improved lives for patients worldwide.

    “The McNeill’s generosity has enabled me to create and implement ambitious plans to improve therapy for HIV treatment, prevention and cure,” Dr. Kashuba said.

    We are Revolutionizing the Possibilities for Health Care

    In a first for medical science, Shawn Hingtgen, Ph.D., turned skin cells into stem cells that hunt down and destroy brain tumors known as glioblastomas. The work represents the newest evolution of stem-cell technology. Dr. Hingtgen and his team have engineered the stem cells to deliver tumor-killing therapeutic agents. It is a breakthrough that could offer, for the first time in more than 30 years, a new and more effective treatment for the devastating disease.

    “Patients desperately need a better standard of care. This is a big step toward a real treatment and making a real difference,” said Dr. Hingtgen. He envisions the concept being adapted to fight other types of brain cancer, including pediatric cases.

    Drs. Kashuba and Hingtgen’s remarkable work attests to our ever-pressing need to support faculty research that improves outcomes and changes lives for the better.

     

    Return to main pageOpens in new window

    More UNC Eshelman School of Pharmacy Funding Priorities

    Explore Stories

    Research

    Discovering Disease Treatments

    Strengthening neuroscience research

    Research

    READDI for the Future

    “READDI has the potential to make sure we are never caught off-guard again.”

    Dean Angela Kashuba
    Leadership

    Focused on helping people live longer, healthier lives

    Renowned researcher and innovator in the fight against HIV/AIDS, Angela Kashuba is ready for a new challenge as dean of UNC Eshelman School of Pharmacy.

    Research

    Minds meet hearts in the hunt for a cure

    Developing personalized treatments for cancer patients is more than a professional path for these UNC researchers; it’s a personal mission.

    Global Impact

    Pharmacy Without Borders

    “It’s incredible to see that kind of impact for our students in an international setting.”

    Research

    A Foot in Two Worlds

    “We’re not trying to treat cells in a dish; we’re trying to treat people.”